Group 1 - The core point of the article is that two major shareholders of Sai Fen Technology (688758) plan to reduce their holdings in the company through centralized bidding and block trading [1] - Anhui Tonghua High-tech Center (Limited Partnership), holding 7.46% of the shares, intends to reduce its stake by up to 12.4939 million shares, which accounts for 3% of the total share capital [1] - Three other shareholders, including Nanjing Huatai Health No.1 Equity Investment Partnership (Limited Partnership), Nanjing Huatai Health No.2 Equity Investment Partnership (Limited Partnership), and Nanjing Daoxing Venture Capital Management Center (General Partnership), also plan to reduce their holdings by up to 12.4939 million shares, representing another 3% of the total share capital [1]

证券代码：688758 证券简称：赛分科技 公告编号：2026-001 苏州赛分科技股份有限公司 关于持股 5%以上股东减持股份计划的公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 大股东持有公司股份的基本情况 截至本公告披露日，安徽同华高新技术中心（有限合伙）（以下简称"同华 高新"）持有苏州赛分科技股份有限公司（以下简称"公司"或"赛分科技"）股 份 31,050,000 股，占公司总股本的 7.46%。 自本公告披露之日起 15 个交易日后的三个月内进行。 大健康一号、大健康二号及道兴投资长期看好公司的发展，因其资金安排原 因，计划通过集中竞价和大宗交易的方式减持其所持有的公司股份不超过 12,493,923 股，减持比例不超过公司总股本的 3%。其中，以集中竞价交易方式 减持其所持有的公司股份数量不超过 4,164,641 股，减持比例不超过公司总股本 的 1%；以大宗交易方式减持其持有的公司股份数量不超过 8,329,282 股，减持 比例不超过公司总股本的 2%，自本公告披露之 ...

Core Viewpoint - The major shareholders of Saifen Technology plan to reduce their holdings in the company between February 3, 2026, and May 2, 2026, due to financial arrangements [1] Shareholder Reduction Plan - Anhui Tonghua High-tech Center and its concerted actions intend to reduce their stake by up to 12.4939 million shares, representing no more than 3% of the total share capital [1] - Nanjing Huatai Health No.1 and No.2 Equity Investment Partnership, along with Nanjing Daoxing Venture Capital Management Center, plan to collectively reduce their holdings by up to 12.4939 million shares, also accounting for no more than 3% of the total share capital [1] - The reduction price will be determined based on market conditions [1]

Market News - China will release December import and export data on January 14, with exports expected to grow by 3.0% year-on-year, down from 5.9% in November, while imports are anticipated to decline by 2.9% [3] - The trade balance for December 2025 will also be published on January 14, with total goods trade from January to November 2025 reaching 41.21 trillion yuan, a year-on-year increase of 3.6% [3] Commodity Futures - The Shanghai Futures Exchange will adjust the price limit for platinum and palladium futures contracts to 16% starting from January 13, 2026, with the trading margin standard set at 18% [4] Energy Outlook - The U.S. Energy Information Administration (EIA) will release its Short-Term Energy Outlook report on January 13, maintaining the WTI crude oil price forecast for 2025 at slightly below $69 per barrel [5] U.S. Economic Data - The U.S. will release December CPI data on January 13, with core CPI expected to rebound significantly, predicted at 0.36% by Morgan Stanley and 0.38% by Bloomberg, both higher than the average of 0.08% in October and November [6] - Key economic indicators including October and November PPI and November retail sales will also be released, with expectations of moderate PPI growth and a 0.7% rebound in retail sales for November [6] Federal Reserve - The Federal Reserve will publish its latest Beige Book on January 14, indicating that government shutdowns and AI applications have weakened the job market, while rising tariffs and healthcare costs have increased business expenses [7] Earnings Season - The earnings season for Q4 2025 will commence this week, with major banks including JPMorgan, Citigroup, and Goldman Sachs set to report [8] Sector Events - The second China eVTOL Innovation Development Conference is scheduled for January 15-16, 2026, in Shanghai, focusing on the new commercial era of eVTOL [10] - The fourth Data Center Liquid Cooling & AI Chip Thermal Management Supply Chain Conference will be held on January 14-15, 2026, in Shenzhen [10] - China's first comprehensive law in the nuclear energy sector, the Atomic Energy Law, will take effect on January 15, 2026 [11] Individual Company News - Hangyu Technology announced on January 11 that it has repurchased 752,800 shares, with plans to sell them within six months [13] - Huadong Medicine's subsidiary has developed a breakthrough treatment for severe hypertriglyceridemia, which has been included in the list of breakthrough therapies by the National Medical Products Administration [13] - Jingfeng Mingyuan plans to acquire 100% of Sichuan Yichong Technology Co., with a key review meeting scheduled for January 16, 2026 [13] - TSMC has commenced research on its next-generation 1.4nm process, with risk trial production expected to start in 2027 [13] Lock-up Expiration - From January 12 to January 16, 2026, 23 companies will have lock-up shares released, totaling 2.434 billion shares with a market value of approximately 48.56 billion yuan [16] - The highest market value of lock-up shares released on January 12 is from Tianxin Pharmaceutical at 7.84 billion yuan [17] New Stock Calendar - Two new stocks are set to be issued this week, with a total issuance of approximately 34 million shares and expected fundraising of 1.909 billion yuan [19] Market Outlook - The current market enthusiasm is driven by concentrated inflows from previously cautious funds, with expectations for continued momentum in thematic and small-cap stocks until after the Two Sessions [22] - Guojin Securities suggests that the spring market is likely to perform well, with a focus on AI investments and the recovery of domestic manufacturing [23] - Everbright Securities anticipates sustained market heat but warns of potential cooling as the Lunar New Year approaches, recommending attention to sectors like electronics and power equipment [24]

作者 | 深水财经社 倪大九 今天是2026年第一个工作日，首先祝大家今年都能收获满满、事业顺遂！ 不声不响间，2025年已经过去。Wind数据显示，截至12月31日收盘，1400多家公司涨幅逾50%，近500家公司涨幅突破100%，更有120多家公司年涨幅超 200%，所以大家都赚到钱没？ 最近，强哥会对2025年江苏A股上市公司进行一个全面的盘点，今天细说的是IPO情况。 2025年，A股共有116家企业成功上市，较2024年增长16%。其中江苏新增A股公司29家，数量位居全国第一。 其中的"领头羊"苏州更创下历史性突破——全年新增12家A股上市公司，数量首次登顶全国各大城市榜首。 2023年"827新政"以来，IPO持续收紧，2024年IPO数量和募资规模跌至十年最低。 2025年，IPO情况有所回暖。A股新上市公司数量116家，募资1318亿元，分别较上年增长16％和104％。 其中，江苏新增29家A股公司，数量位居全国第一，领先广东（21家）和浙江（17家），占全国新增总数的四分之一。 这样一来，江苏的A股公司总数就达到了721家，距离第二名浙江仅10家的差距，这样下去到明年很可能会追平浙江。 细数 ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 本次股票上市类型为首发战略配售股份（限售期12个月）；股票认购方式为网下，上市股数为 4,997,569股。本公司确认，上市流通数量等于该限售期的全部战略配售股份数量。 ● 除首发战略配售股份外，本次其他股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 250,706,767股。 本次股票上市流通总数为255,704,336股。 ● 本次股票上市流通日期为2026年1月12日。（因2026年1月10日为非交易日，故顺延至下一交易日） 一、本次上市流通的限售股类型 根据中国证券监督管理委员会（以下简称"中国证监会"）于2024年8月22日出具的《关于同意苏州赛分 科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2024〕1204号），公司获准首次向社会 公众公开发行人民币普通股（A股）股票4,997.5690万股，并于2025年1月10日在上海证券交易所科创板 上市。公司首次公开发行股票完成后，总股本为416,464,084股，其中有限售条 ...

中信证券股份有限公司 关于苏州赛分科技股份有限公司 首次公开发行部分限售股及部分战略配售限售股上市流通 的核查意见 中信证券股份有限公司（以下简称"中信证券"、"保荐人"）作为苏州赛 分科技股份有限公司（以下简称"赛分科技"、"公司"）首次公开发行股票并 在科创板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上海证券交 易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》 等有关法律法规和规范性文件的要求，就赛分科技首次公开 发行部分限售股及部分战略配售限售股上市流通的事项进行了专项核查： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2024 年 8 月 22 日出具的《关于同意苏州赛分科技股份有限公司首次公开发行股票注册的批 复》（证监许可〔2024〕1204 号），公司获准首次向社会公众公开发行人民币 普通股（A 股）股票 4,997.5690 万股，并于 2025 年 1 月 10 日在上海证券交易所 科创板上市。公司首次公开发行股票完成后，总股本为 416,464,084 股，其中有 限售条件流通股 376,959, ...

每经AI快讯，赛分科技（SH 688758，收盘价：17.93元）12月29日晚间发布公告称，公司限售股份约 2.56亿股将于2026年1月12日解禁并上市流通，占公司总股本比例为61.4%。 每经头条（nbdtoutiao）——直击茅台经销商大会：2000多人周末齐聚！重大变革公布：涉及茅台酒价 格、分销等，董事长陈华：经销商不能再"躺着赚钱" （记者 曾健辉） 2024年1至12月份，赛分科技的营业收入构成为：药物分析占比40.2%，抗体药物占比20.85%，胰岛素/ 多肽/GLP-1占比18.18%，重组蛋白占比13.73%，其他占比6.6%。 截至发稿，赛分科技市值为75亿元。 ...

证券代码：688758 证券简称：赛分科技 公告编号：2025-040 苏州赛分科技股份有限公司 首次公开发行部分限售股及部分战略配售限售股上市 流通公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次股票上市类型为首发战略配售股份（限售期 12 个月）；股票认购方 式为网下，上市股数为4,997,569股。本公司确认，上市流通数量等于该限售期的 全部战略配售股份数量。 除首发战略配售股份外，本次其他股票上市类型为首发限售股份；股票认 购方式为网下，上市股数为250,706,767股。 本次股票上市流通总数为255,704,336股。 本次股票上市流通日期为2026 年 1 月 12 日。（因 2026 年 1 月 10 日为非 交易日，故顺延至下一交易日） 1、股东南京华泰大健康一号股权投资合伙企业（有限合伙）（以下简称"华泰 大健康一号"）、南京华泰大健康二号股权投资合伙企业（有限合伙）（以下 简称"华泰大健康二号"）、南京道兴创业投资管理中心（普通合伙） "1.自发行人股票上市之日起 12 个月 ...

Group 1 - The core viewpoint of the news is that Sai Fen Technology's stock performance and financing activities indicate a mixed market sentiment, with a slight decline in stock price and notable financing activities on December 18 [1][2]. - On December 18, Sai Fen Technology's stock price fell by 1.03%, with a trading volume of 28.69 million yuan. The financing buy-in amount was 2.43 million yuan, while the financing repayment was 3.11 million yuan, resulting in a net financing buy of -0.68 million yuan [1]. - As of December 18, the total balance of margin trading for Sai Fen Technology was 48.84 million yuan, with a financing balance of 48.77 million yuan, accounting for 6.30% of the circulating market value [1]. Group 2 - Sai Fen Technology, established on March 16, 2009, is located in the Suzhou Industrial Park and specializes in the research and production of liquid chromatography materials for drug analysis and purification [2]. - The company's main business revenue composition includes: industrial purification segment 33.10%, industrial purification fillers 32.65%, analytical chromatography segment 16.73%, analytical chromatography columns 13.31%, analytical chromatography fillers 3.13%, and other segments [2]. - For the period from January to September 2025, Sai Fen Technology achieved an operating income of 302 million yuan, representing a year-on-year growth of 38.39%, and a net profit attributable to shareholders of 93.21 million yuan, with a year-on-year increase of 71.07% [2]. Group 3 - After its A-share listing, Sai Fen Technology has distributed a total of 27.90 million yuan in dividends [3]. - As of September 30, 2025, the number of shareholders for Sai Fen Technology was 7,159, a decrease of 31.51% from the previous period, while the average circulating shares per person increased by 57.01% to 5,933 shares [2][3]. - Among the top ten circulating shareholders, the Southern Science and Technology Innovation Board 3-Year Open Mixed Fund (506000) has exited the list [3].